Stock listing
OTC:ASCLF Ascletis Pharma, Inc. Stock
US listing (OTC) of Ascletis Pharma, Inc. · home listing HKEX:1672
Follow Ascletis Pharma, Inc. into a list and get an email when it puts out news.
Share price · OTC:ASCLF
$0.625 USD -0.095 (-13.2%)
Close on Nov 10, 2026
- Day range
- $0.620 – $0.625 USDNov 10, 2026
- Volume
- 5,350 sharesNov 10, 2026
- 52-week range
- $0.620 – $2.500 USDLowest and highest trades, Nov 11, 2025 – Nov 10, 2026
- Traded on an average day
- $972 USDMedian day 0 shares · 44 days with no trades · last 3 months, Aug 10, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:1672 · Home | $4.37 HKD | +0.005 (+0.1%) | 585,080 | $4.365 | $4.50 | $4.175 | $4.365 | Close on Nov 18, 2026 |
| OTC:ASCLF | $0.625 USD | -0.095 (-13.2%) | 5,350 | $0.620 | $0.625 | $0.620 | $0.720 | Close on Nov 10, 2026 |
| Frankfurt:2VJ | €0.494 EUR | +0.010 (+2.1%) | — | €0.496 | €0.496 | €0.494 | €0.484 | Close on Nov 17, 2026 |
| Stuttgart:2VJ | €0.494 EUR | +0.012 (+2.5%) | — | €0.494 | €0.494 | €0.492 | €0.482 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 10, 2026 – Nov 6, 2026 · OTC:ASCLF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.720 | 0.000 | 0.0% | $0.720 | $0.720 | $0.720 | 0 | |
| $0.720 | 0.000 | 0.0% | $0.720 | $0.720 | $0.720 | 0 | |
| $0.720 | 0.000 | 0.0% | $0.720 | $0.720 | $0.720 | 0 | |
| $0.720 | 0.000 | 0.0% | $0.720 | $0.720 | $0.720 | 0 | |
| $0.720 | 0.000 | 0.0% | $0.720 | $0.720 | $0.720 | 0 | |
| $0.720 | 0.000 | 0.0% | $0.720 | $0.720 | $0.720 | 0 | |
| $0.720 | 0.000 | 0.0% | $0.720 | $0.720 | $0.720 | 0 | |
| $0.720 | 0.000 | 0.0% | $0.720 | $0.720 | $0.720 | 0 | |
| $0.720 | -0.010 | -1.4% | $0.720 | $0.720 | $0.720 | 5,000 | |
| $0.730 | 0.000 | 0.0% | $0.730 | $0.730 | $0.730 | 0 | |
| $0.730 | 0.000 | 0.0% | $0.730 | $0.730 | $0.730 | 0 | |
| $0.730 | -0.040 | -5.2% | $0.730 | $0.730 | $0.730 | 3,002 | |
| $0.770 | +0.020 | +2.7% | $0.770 | $0.770 | $0.770 | 800 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | 0.000 | 0.0% | $0.750 | $0.750 | $0.750 | 0 | |
| $0.750 | -0.130 | -14.8% | $0.750 | $0.750 | $0.750 | 5,000 | |
| $0.880 | 0.000 | 0.0% | $0.880 | $0.880 | $0.880 | 0 | |
| $0.880 | -0.210 | -19.3% | $0.880 | $0.880 | $0.880 | 5,000 | |
| $1.090 | 0.000 | 0.0% | $1.090 | $1.090 | $1.090 | 0 | |
| $1.090 | 0.000 | 0.0% | $1.090 | $1.090 | $1.090 | 0 | |
| $1.090 | +0.050 | +4.8% | $1.090 | $1.090 | $1.090 | 275 | |
| $1.040 | 0.000 | 0.0% | $1.040 | $1.040 | $1.040 | 0 | |
| $1.040 | 0.000 | 0.0% | $1.040 | $1.040 | $1.040 | 0 | |
| $1.040 | -0.080 | -7.1% | $1.040 | $1.040 | $1.040 | 5,000 | |
| $1.120 | 0.000 | 0.0% | $1.080 | $1.120 | $1.080 | 3,210 | |
| $1.120 | +0.060 | +5.7% | $1.080 | $1.120 | $1.080 | 2,102 | |
| $1.060 | -0.140 | -11.7% | $1.060 | $1.060 | $1.060 | 900 | |
| $1.200 | 0.000 | 0.0% | $1.200 | $1.200 | $1.200 | 0 | |
| $1.200 | 0.000 | 0.0% | $1.200 | $1.200 | $1.200 | 0 | |
| $1.200 | 0.000 | 0.0% | $1.200 | $1.200 | $1.200 | 0 | |
| $1.200 | 0.000 | 0.0% | $1.200 | $1.200 | $1.200 | 0 | |
| $1.200 | 0.000 | 0.0% | $1.200 | $1.200 | $1.200 | 0 | |
| $1.200 | +0.100 | +9.1% | $1.180 | $1.200 | $1.180 | 1,375 | |
| $1.100 | 0.000 | 0.0% | $1.100 | $1.100 | $1.100 | 0 | |
| $1.100 | 0.000 | 0.0% | $1.100 | $1.100 | $1.100 | 0 | |
| $1.100 | -0.100 | -8.3% | $1.100 | $1.100 | $1.100 | 1,000 | |
| $1.200 | 0.000 | 0.0% | $1.200 | $1.200 | $1.200 | 0 | |
| $1.200 | -0.010 | -0.8% | $1.210 | $1.210 | $1.200 | 13,007 | |
| $1.210 | -0.090 | -6.9% | $1.210 | $1.210 | $1.210 | 4,998 | |
| $1.300 | 0.000 | 0.0% | $1.300 | $1.300 | $1.300 | 1,000 | |
| $1.300 | 0.000 | 0.0% | $1.300 | $1.300 | $1.300 | 0 | |
| $1.300 | 0.000 | 0.0% | $1.300 | $1.300 | $1.300 | 0 | |
| $1.300 | +0.020 | +1.6% | $1.300 | $1.300 | $1.300 | 1,200 | |
| $1.280 | 0.000 | 0.0% | $1.280 | $1.280 | $1.280 | 0 | |
| $1.280 | 0.000 | 0.0% | $1.280 | $1.280 | $1.280 | 0 | |
| $1.280 | -0.020 | -1.5% | $1.280 | $1.280 | $1.280 | 410 | |
| $1.300 | 0.000 | 0.0% | $1.300 | $1.300 | $1.300 | 0 | |
| $1.300 | 0.000 | 0.0% | $1.300 | $1.300 | $1.300 | 1,000 | |
| $1.300 | 0.000 | 0.0% | $1.300 | $1.300 | $1.300 | 0 | |
| $1.300 | 0.000 | 0.0% | $1.300 | $1.300 | $1.300 | 0 | |
| $1.300 | 0.000 | 0.0% | $1.300 | $1.300 | $1.300 | 0 | |
| $1.300 | 0.000 | 0.0% | $1.300 | $1.300 | $1.300 | 0 | |
| $1.300 | 0.000 | 0.0% | $1.300 | $1.300 | $1.300 | 0 | |
| $1.300 | 0.000 | 0.0% | $1.300 | $1.300 | $1.300 | 0 | |
| $1.300 | 0.000 | 0.0% | $1.300 | $1.300 | $1.300 | 0 | |
| $1.300 | -0.040 | -3.0% | $1.300 | $1.300 | $1.300 | 1,650 | |
| $1.340 | 0.000 | 0.0% | $1.340 | $1.340 | $1.340 | 0 | |
| $1.340 | +0.135 | +11.2% | $1.340 | $1.340 | $1.340 | 3,000 | |
| $1.205 | 0.000 | 0.0% | $1.205 | $1.205 | $1.205 | 0 | |
| $1.205 | 0.000 | 0.0% | $1.205 | $1.205 | $1.205 | 0 | |
| $1.205 | 0.000 | 0.0% | $1.205 | $1.205 | $1.205 | 0 | |
| $1.205 | 0.000 | 0.0% | $1.205 | $1.205 | $1.205 | 0 |
- Ticker
- OTC:ASCLF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 17, 2026
Voluntary announcement - ascletis submits IND application to the U.S. FDA for ASC36_37O FDC, a potentially first-in-class once-weekly oral quadruple peptide agonist targeting amylin receptor, GLP-1R, GIPR and GCGR, for the treatment of obesity
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 23 slides
Latest news
Next Day Disclosure Return
Nov 6, 2026
Closed $0.72 (0.0%) on Nov 6, 2026
Grant of share options
Nov 4, 2026
Closed $0.72 (0.0%) on Nov 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Nov 4, 2026
Closed $0.72 (0.0%) on Nov 4, 2026
Voluntary announcement - ascletis to present study results of oral small molecule GIPR agonist ASC48 and GLP-1R/GIPR/GCGR triple peptide agonist ASC37 at ObesityWeek 2026
Nov 2, 2026
Closed $0.72 (0.0%) on Nov 2, 2026
Voluntary announcement - ascletis' oral small molecule GLP-1, ASC30, demonstrated placebo-adjusted HBA1C reduction of 1.7% at 12 weeks from its U.S. phase II study in participants with diabetes
Oct 28, 2026
Closed $0.72 (0.0%) on Oct 29, 2026
Decks
Investor Presentation (November 2026)
Investor deck · 23 slides · November 2026
Investor Presentation (October 2026)
Investor deck · 23 slides · Oct 21, 2026
Investor Presentation (August 2026)
Investor deck · 22 slides · August 2026
EASD 2026
Conference · 8 slides · 2026
Ascletis Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 57 in the last 12 months · 88 in all · newest Nov 17, 2026 · oldest 2025
- Decks
- 6 decks · latest November 2026
Where Ascletis Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:1672 歌禮製藥 · Home listing | HKEX | Hong Kong | HKD |
| Tradegate:2VJ | Tradegate | Germany | EUR |
| OTC:ASCLF · This page | OTC | United States | USD |
| LS Exchange:A2JRKN | LS Exchange | Germany | EUR |
| gettex:2VJ | gettex | Germany | EUR |
| Lang & Schwarz:A2JRKN | Lang & Schwarz | Germany | EUR |
| Frankfurt:2VJ | Frankfurt | Germany | EUR |
| Dusseldorf:2VJ | Dusseldorf | Germany | EUR |
| Munich:2VJ | Munich | Germany | EUR |
| Stuttgart:2VJ | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Ascletis Pharma, Inc.